Research rticle
Synthesis, Characterization, and Antimicrobial Activity of Novel
Sulfonated Copper-Triazine Complexes
Supun Katugampala,
1
Inoka C. Perera,
2
Chandrika Nanayakkara,
3
and Theshini Perera
1
1
Department of Chemistry, University of Sri Jayewardenepura, Nugegoda, Sri Lanka
2
Department of Zoology and Environment Science, University of Colombo, Colombo, Sri Lanka
3
Department of Plant Science, University of Colombo, Colombo, Sri Lanka
Correspondence should be addressed to eshini Perera; theshi@sjp.ac.lk
Received 6 April 2018; Revised 5 June 2018; Accepted 8 July 2018; Published 29 August 2018
Academic Editor: Aurel Tabacaru
Copyright © 2018 Supun Katugampala et al. is is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Metallotriazine complexes possess interesting biological and medicinal properties, and the present study focuses on the
synthesis, characterization, and antimicrobial activity of four novel copper-triazine derivatives in search of potent antibacterial
and antifungal drug leads. In this study, 3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine-4,4′-disulfonic acid monosodium salt (L1,
ferrozine) and 3-(2-pyridyl)-5,6-di(2-furyl)-1,2,4-triazine-5,5′-disulfonic acid disodium salt (L2, ferene) have been used as
ligands to study the complexation towards copper(II). e synthesized complexes, [CuCl
2
(ferrozine)]·7H
2
O·MeOH ( 1),
[CuCl
2
(ferrozine)
2
]·5H
2
O·MeOH (2), [CuCl
2
(ferene)]·H
2
O·MeOH (3), and [CuCl
2
(ferene)
2
]·H
2
O·MeOH (4), have been
characterized spectroscopically, and preliminary bioassays have been carried out. FTIR spectroscopic data have shown that
N�NandC�N stretching frequencies of complexes have been shifted towards lower frequencies in comparison with that of the ligands,
confirming new bond formation between Cu and N, which in turn lowers the strength of N�N and C�N bonds. In addition,
a bathochromic shift has been observed for UV-visible spectra of complexes ( 1), (2), (3), and (4). Furthermore, elemental analysis data
have been useful to obtain empirical formulas of these complexes and to establish the purity of each complex. Complexes ( 1)and(2) have
shown antibacterial activity for both S. aureus (ATCC
®
25923) and E. coli (ATCC
®
25922) at 1mg/disc concentration, and ferrozine has
shown a larger inhibition zone against the clinical sample of C. albicans at 1mg/disc concentration in comparison with the positive
control, fluconazole.
1. Introduction
Transition metals have numerous and unique biological,
chemical, and physical properties due to the availability
of d electrons in valance shells. Much attention has been
focused on copper complexes due to their various potential
biological activities [1–4] out of which antimicrobial [5] and
antiviral activities is paramount [6–15].
Since triazine is a well-known natural material which
possesses many biological properties [16–21], it is not sur-
prising that organometallic complexes of triazine with first
row transition metals (Mn [22, 23], Co [24, 25], Ni [24, 25],
Cu [22, 24–28], and Zn [25]), with second row transition
metals (Ru [29], Pd [30], Ag [31], and Cd [32]), and with
third row transition metals (Re [33] and Pt [34–36]) have
been synthesized, and their activities explored as catalysts
[37] and biological agents such as antibacterial [25], anti-
cancer [29, 36], antifouling [24], antifungal [33], anti-HIV
[35], antimicrobial [25], antiproliferative [26, 34], antiviral
[28, 35], and DNA binding [26, 29, 30] agents.
Even though many reports exist of metal complexes of
triazine derivatives as detailed above, metal complexes con-
taining the pyridyl-1,2,4-triazine core are relatively un-
explored. Platinum(II) complexes of sulphonated 2-pyridyl-
1,2,4-triazine have been reported to possess anti-HIV activity
[35]. A copper(II) complex bearing 2,4,6-tris(2-pyridyl)-1,3,5-
triazine ligand has been reported to bind DNA in a moder-
ately strong way exhibiting significantly better anticancer
activity against breast cancer in comparison with cisplatin
[26]. An octahedral complex of rhenium(V), ML1L2L3L4
Hindawi
Bioinorganic Chemistry and Applications
Volume 2018, Article ID 2530851, 7 pages
https://doi.org/10.1155/2018/2530851